Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 1, 1999, Pages 21-29

  Janssen, Edith M ^b   Wauben, Marca H M ^b   Jonker, Eline H ^b   Hofman, Gerard ^b   Van Eden, Willem ^b   Nijkamp, Frans P ^b   Van Oosterhout, Antoon J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE;

CYTOKINE; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; OVALBUMIN;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; DISEASE MODEL; DOSE RESPONSE; EOSINOPHILIA; HELPER CELL; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; LUNG LAVAGE; MALE; METABOLISM; MOUSE; RESPIRATORY TRACT ALLERGY;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EOSINOPHILIA; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033161386     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.1.3519     Document Type: Article

References (36)

1. Barnes, P. J, 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J. Allergy Clin. Immunol. 83:1013-1026.
2. Gagnon, R., J. Lian, Y. Boulin, and J. Hébert. 1993. Seasonal enhancement of 1L-4 induced IgE synthesis by peripheral blood mononuclear cells of alopic patients. Clin. Exp. Allergy 23;498-503.
3. Walker, C., W. Bauer, R. K. Braun, G. Menz, F. Braun, F. Schwartz, T. T. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in broncho-alveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150:1038-1048.
4. Coyle, A. J., G. Le Gros, C. Bertrand, S. Tsuyuki, C. H. Heusser, M. Kopf, and G. P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54-59.
5. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3799.
6. Del Prete, G., E. Maggi, P. Paola, I. Ghretien, A. Tiri, D. Macchia, J. Banchereau, J. E. de Vries, and S, Romagnani. 1988. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatant. J. Immunol. 140:4193-4198.
7. Warringa, R. A. J., R. C. Schweizer, T. Maikoc, P. H. M. Kuijper, P. L. B. Bruijnzeel, and L. Koenderman. 1992. Modulation of cosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell Mol. Biol. 7:631-637.
8. Simon, H. U., and K. Blaser. 1995. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol. Today 16:53-55.
9. O'Hehir, R. E., H. Yssel, S. Verma, J. E. de Vries, H. Spits, and J. R. Lamb. 1991. Clonal analysis of differential lymphokine secretion in peptide and superantigen induced anergy. Int. Immunol. 3:819-824.
10. Yssel, H., S. Fasler, J. Lamb, and J. E. de Vries. 1994. Induction of non-responsiveness in human allergen-specific type 2 helper cells. Curr. Opin. Immunol. 6:847-852.
11. Fairchild, P. J., C. J. Thorpe, P. J. Travers, and D. C. Wraith. 1994. Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology 81:487-496.
12. Metzler, B., and D. C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1159-1163.
13. Aichele, P., D. Kyburz, P. S. Ohashi, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1994. Peptide induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 91:444-448.
14. Gaur, A., B. Wiers, A. Liu, J. Rothhard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 248:1491-1495.
15. Briner, T. J., M.-C. Kuo, K. M Keating. B. L., Rogers, and J. L. Greenstein. 1993. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen FeI d I. Proc. Natl. Acad. Sci. U.S.A. 90:7608-7612.
16. Hoyne, G. F., B. A. Askonas, C. Hetzel, W. R. Thomas, and J. R. Lamb. 1996. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335-342.
17. Hessel, E. M., A. J. M. van Oosterhout, C. L. Hofstra, J. J. de Bie, J. Garssen, H. van Loveren, A. K. C. Verheyen, H. F. J. Savelkoul, and F. P. Nijkamp. 1995. Bronchoconstriction and airway hyperresponsiveness after OVA inhalation in sensitized mice. Eur. J. Pharmacol. 293:401-412.
18. + T cells produce Th2 type cytokines in a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 155:A735. (Abstr.)
19. Van Oosterhout, A. J. M., B. van Esch, G. Hofman, C. L. Hofstra, I. van Ark, F. P. Nijkamp, M. L. Kapsenberg, H. F. J. Savelkoul, and F. R. Weller. 1998. Allergen immunotherapy inhibits airway cosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am. J. Respir. Cell Moll. Biol. 19:622-628.
20. Buus, S., S. Colon, C. Smith, J. H. Freed, C. Miles, and H. M. Grey. 1986. Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc. Natl. Acad. Sci. U.S.A. 83:3968-3974.
21. Renz, H., K. Bradley, G. L. Larsen, C. McCall, and F. W. Gelfand. 1993. Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339: differential expansion of Vβ-expressing T cell populations. J. Immunol. 151:7206-7213.
22. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4 but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
23. Korsgren, M., J. S. Erjefäll, O. Korsgren, F. Sundler and C. G. A. Persson. 1997. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J. Exp. Med. 185:885-892.
24. Mehlhop, P. D., M. Rijn, A. B. Goldberg, J. P. Brewer, V. P. Kurup, T. R. Marlin, and H. C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. U.S.A. 94:1344-1349.
25. Djurup, R. 1985. The subclass and nature of the IgG antibody response in patients undergoing allergen specific immunotherapy. Allergy 40:469-486.
26. Muller, U., A. Helbling, and M. Bischof. 1989. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 44:412-418.
27. Ebner, C., U. Siemann, and B. Bohle. 1997. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T cell clones specific for Ph1 p I, a major grass pollen allergen. Clin. Exp. Allergy 27:1007-1015.
28. McHugh, S. M., J. Deighton, A. G. Stewart, P. J. Lachman, and P. W. Ewan. 1995. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional therapy. Clin. Exp. Allergy 25:828-838.
29. Akoum, H., A. Tsicopoulos., H. Vorng, B. Wallaert, J. P. Dessaint, M. Joseph, Q. Hamid, and A. B. Tonnel. 1996. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes. Immunology 87:593-598.
30. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J. Allergy Clin. Immunol. 97: 1356-1365.
31. Jutel, M., W. J. Pilcher, D. Skrbie, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in a decrease of IL-4 and IL-5 and increase of 1FN-gamma secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154:4187-4194.
32. Akdis, C. A., M. Akdis, T. Bleskon, D. Wymann, S. S. Alkan, U. Muller, and K. Blaser. 1996. Epitope-specific tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98:1676-1683.
33. Tilney, N. L. 1971. Patterns of lymphatic drainage in the adult laboratory rat. J. Anal. 109:369-383.
34. Norman, P. S., J. L. Ohman, A. A. Long, P. S. Creticos, M. A. Gefter, Z. Shaked, R. A. Wood, P. A. Eggleston, K. D. Hafner, P. Rao, L. M. Liehtenstein, N. H. Jones, and C. F. Nicodemus. 1996. Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care Med. 154:1623-1628.
35. Guery, J.-C., F. Ria, F. Galbiati, S. Smiroldo, and L. Adorini. 1997. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells. Int. Immunol. 9:9-15.
36. Duncan, D. D., and S. L. Swain. 1994. Role of antigen-presenting cells in polarized development of helper T cell subsets; evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 4:2506-2514.